STATE STREET CORP

Position in GHRS — GH Research PLC

CIK 93751 BOSTON, MA

Position in GHRS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$300,061

+$144,713 QoQ

Shares Held

11,163

+1.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 62 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. GHRS ranks #322 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$300,061	11,163	+1.0%	Shares	Defined	2026-08-07
2026-03-31	$155,348	11,049	+2.1%	Shares	Defined	2026-05-15
2025-12-31	$137,426	10,821	-1.6%	Shares	Defined	2026-02-13
2025-09-30	$157,185	10,992	+2.7%	Shares	Defined	2025-11-14
2023-12-31	$62,083	10,704	0.0%	Shares	Defined	2024-02-14
2023-09-30	$107,575	10,704	0.0%	Shares	Defined	2023-11-14
2023-06-30	$127,002	10,704	-1.8%	Shares	Defined	2023-08-14
2023-03-31	$87,059	10,896	-0.4%	Shares	Defined	2023-05-15
2022-12-31	$106,375	10,944	+0.4%	Shares	Defined	2023-05-15
2022-09-30	$126,611	10,896	—	Shares	Defined	2022-11-15
No filing history on record for this holder in this stock.